CytoDyn Inc (QB) (CYDY) News

Massive green all over the market! Oh... Yeeaaahhhh, sorry CYDY, well at least you're up 0.1% LAUGHING

I have never said Tanya is the greatest

No, actually what you said was...
Monroe1

Re: None

Thursday, September 12, 2024 11:35:25 AM

Post#
233450
of 233475
Tanya is doing an excellent job all the way around. More power to her.

You have continually tried to find some mythical enemies coming to steal from this company, however, the company itself has just put out a message to shareholders that they are years away from having a product. WHO in the world is worried about this company?
There are no shorts or paid bashers. There are paid promoters however.....aren't there?

Way more long and way more knowledgeable. These short fools have run out of ammunition and are now trying to find some low hanging fruit.
I have never said Tanya is the greatest, but is part of the team that has put us back on track. Only shorts and paid bashers from some competing source dedicate themselves to attacking posters and a stock. Leronlimab poses a great threat to many a club member with big friends with tons tied
up in a lot of companies. Plain and simple that these types try to camouflage themselves as fake longs.

$$$CYDY$$$ 2024 Good job team!!

You don’t think we have pounded sand on this board?

You think we would like to hug that stupido BOD?

Where’ve you been lately..,

you've lost me. what does the number of chat board posts have to do with whether someone is long? I'd argue the opposite. You have clowns like fungderf who have admitted they have no stake - and they post 25 times a day. i think there are a good number of paid promoters or bashers on here - and the more daily posts, the more likely that's what they are.

my point is that if you've truly been long this stock - and lost most of your money - how can you not be frustrated and pushing for a greater sense of urgency from management and the board.

About Monroe: "Clearly has not been a long, or wouldn't be taking this "all is well" BS stance."

Can we use a little fact, BlueH? A couple of statistics.

Your stats are: joined iHub 6/2/2017 and frequent two boards and have amassed 729 posts.
Monroe's stats are: joined 5/30/2012, and frequents only one board (CYDY) and has amassed (drum roll, please) 29,716 posts. I believe he is more
long than you.

I like Kool-Aid so much, I bathe in it.

Not sure I missed??

Stated VERY clearly--she is there for privvy investors ONLY--FULL STOP
That is not retail--that is not the schlepps. Not that any retail EVER cares or they would have voted nodder out MANY years ago

So I doubt they will remove Tonya--if its a "vs: situation"-- it is retail shares vs: privvy shares and see how votes fall

She needs to go --what she allowed from/for weed/wine and the waste his salary/bonus for his antics--she should have been removed

you're right about that - the traders, the shorts, the lawyers, Paulson, and the board members (like Tanya and the other zombies who have done nothing) are the only ones who have made money here. And they've taken it straight out of the pockets of the common shareholders.

As for me, i'm voting against all of the board members going forward. That's about all a fed-up shareholder can do.

LOL....funny that you would read my post and interpret it that way. This isn't a question of work stoppage due to a fear of risk. This is a person hired with a knowledge to know how to reward insiders and stay within the guidelines.
Many of you seem to forget this is a penny stock with no actual marketable product. Money is being made, just not by the common shareholders.
Look at the trades this morning to push the share price up...A trade of 15000 shares is about $2k. Watch the trades at the end of the day.

09/17/24 10:00:46 AM 5 10300 0.1698
09/17/24 09:59:20 AM 5 2999 0.1699
09/17/24 09:59:13 AM 5 2000 0.1698
09/17/24 09:59:10 AM 5 5000 0.1698
09/17/24 09:59:09 AM 5 2000 0.1698
09/17/24 09:59:07 AM 5 8000 0.1664
09/17/24 09:59:07 AM 5 8000 0.1698
09/17/24 09:58:55 AM 5 3500 0.1664
09/17/24 09:56:21 AM 5 19500 0.1650
09/17/24 09:56:04 AM 5 2 0.1640 e
09/17/24 09:55:59 AM 5 300 0.1650
09/17/24 09:55:59 AM 5 500 0.1650
09/17/24 09:50:43 AM 5 15000 0.1650
09/17/24 09:49:05 AM 5 3000 0.1674
09/17/24 09:48:53 AM 5 15000 0.1650
09/17/24 09:48:47 AM 5 5000 0.1649
09/17/24 09:48:44 AM 5 31000 0.1650
09/17/24 09:48:19 AM 5 800 0.1639
09/17/24 09:48:14 AM 5 3900 0.1639
09/17/24 09:48:14 AM 5 20000 0.1639

I was there for his time also. However,you have missed facts about tayna. No scientific experience at all. No deals 2 years. Stock has sunk to new lows under her leadership. No clear path to any new deals or real trials. She has represented paulson more than shareholders. Under normal conditions she would have been fired a ways back.

yes, her bio is the key here. she is a financial / wealth advisor - as well as an attorney. a compliance person dealing with wealth advisors more specifically. I spent years in the financial space and know these types very well. the compliance lawyers are the most risk averse, anti-business people you will ever come across. They take weeks and months to do something that should take a day - because they are focused on the risk side of the equation, almost to the exclusion of all else.

the reality is, she came in to clean up the mess that Nader created - and at that point, it was 100% damage control. But that time has passed. We now have the ultimate "stick-in-the-mud" as our COB. She also has no clue about biotech or pharma, again because she has no experience in the industry. Time to get rid of her - because we can't afford to have the most powerful person in this company (in such a dynamic and fast-moving space) be a wealth management compliance officer, with zero industry expertise. It's an embarrassment, and you would never see something like that in a legitimate biotech company.

Maybe you missed the disgusting filth that was ceo for 10 years before her . Ran a kickback fraud scheme with his countryman khazem thru a CRO company. This duo is AKA khazempourhassan.
It resulted in hundreds of millions of $$ going into both their pockets , millions wasted defending losing lawsuits. Giving out massive awards and bonus' to all board members and all mngmt. For years. Phony "acquisitions"--phony divorce settlements--phony "fired for cause" scams. Phony BLA submissions--phony BTD submissions--years and years

Still defended by some--applauded by others

Now the company has SEC and DOJ investigations ongoing. The company cannot register/sale shares on open market. The company had hold placed on U S clinical trials. The company did not pay multiple suppliers. Did not pay multiple contractors.
All defended by many. Applauded by most

Tonya is just protecting the privvy investors--FULL STOP.

The nodder was just cheating and stealing from ALL--FULL STOP

I literally almost fell out of my chair! Are you considering changing your name to I_kinda_think_I_still_like_CYDY?
BTW, Tanya has done a decent job of what she was hired to do. She's not here to improve shareholder value, she's here with legal advice on how to work the rules to favor insiders.

Biography
Ms. Tanya Durkee Urbach serves as Independent Chairman of the Board of the Company. Ms. Urbach has been a director since November 24, 2021, and has served as our Board Chair since January 24, 2022. She is currently Partner/Head of Family Office for Eagle Bay Advisors, which provides family office and investment advisory services, and also provides corporate governance and corporate finance advice to Dynepic, Inc., which provides an integrated platform to power immersive training programs for companies and U.S. military forces. From November 2020 through March 31, 2021, Ms. Urbach was a sole practitioner advising broker-dealers, investment advisers and their professionals. From January 2019 through October 2020, she was a shareholder at the law firm Markun, Zusman, Freniere & Compton in Portland, Oregon. She served as General Counsel for Paulson Investment Company, LLC, a registered broker-dealer that provides investment banking services to the Company from time to time, from July 2015 until January 2019, providing advice regarding corporate governance, securities regulatory compliance, corporate finance, and other legal and securities-related issues. Ms. Urbach earned her bachelors degree at University of Oregon and her law degree at Lewis & Clark Law School. She served on the Executive Committee of the Oregon State Bar Securities Regulation Section from 2007 through 2015 and 2019 to 2021. She brings extensive training and expertise in the conduct of securities offerings, securities litigation, corporate finance and business growth, corporate governance, and other corporate business and legal issues to the Board.BTW, if I were a shareholder I'd be a bit ticked that while the stock price has gone from $1.04 in 12/21 to .275 in 12/23 (currently .1499), she has voted herself a hefty raise.

Total Compensation
Period End Date 2023 2022
Currency USD USD
Salary
Bonus
Total Annual Compensation 100,389 35,661
Restricted Stock Awards 100,000 45,526
All Other Compensation
Fiscal Year Total Compensation 200,389 81,187

exactly. As Benjamin Franklin said "Blame-All and Praise-All are two blockheads". Monroe has zero credibility with me with his/her pie in the sky optimism. I maintain that Monroe is getting paid to promote the company. Clearly has not been a long, or wouldn't be taking this "all is well" BS stance.

At the end of the day, shareholder value is the name of the game here. Sure, we want to save lives, but anyone who says they're here just for that is full of it. This is an investment - and the scorecard for an investment is the share price, and if investors have made or lost money. Using that as our scorecard, current leadership gets an F. In fact, If there was anything lower than F, they'd get that - because I'm down over 80% in after-tax dollars. In the greatest bull market in history (with most investments doubling or tripling over the past 5 years), you can't find anything else that has crushed investors like this POS.

I've got nothing personal against Tanya - she's simply a wealth management lawyer and way out of her depth. It's not her fault that she's totally incompetent in this role - but as a shareholder, it's time we start demanding change and finding someone with a sense of urgency here.

I agree with you Big Bopper. It’s one thing to be positive but Monroe is drinking WAY TOO MUCH KOOLAID! How can ANYONE approve of the great job Tanya has done? She’s done a ‘great job’ damaging shareholder value for sure !

Are you another board member . Please,stock has crumbled under her leadership. Not one study going under her leadership. She represents paulson. She has zero scientific backround. She has got us zero deals. I think her and board should tells us if any deals proposed and let stockholders determine if deal is to our benefit. Its scrarry to think you believe she has done great job. Fyi, i am absolutely a long with a lot of stock.

TIK TOK.

I do love weekends especially the long ones when they come around.
CytoDyn undeniably has turned things around. Great minds continue to
be attracted to the science of leronlimab. It's not just the money. They want
to be associated with the next greatest thing in medicine so hence we are blessed to have
their continued association for the most part. Now that the old ceo has been replaced
we will see even greater longevity among those on our team. Thanks toDr. J especially.
What a masterful job he has done. So what happened to the dips? Ahhm hungry.

So who will that collaborator be? What day kicks off the next trial? 4th Q 2024 $$$CYDY$$$
Wondering how high the pps will jump?

I agree. all of the wounds of this company have been self-inflicted - Nader was an unmitigated disaster in every way, and the fallout has been massive. the conspiracy theories of this company being "targeted" by big pharma, the FDA, etc. - has always been a complete joke. CytoDyn under Nader was a very bad actor - submitting false data, Nader's fraudulent trading, partnership with Martin Shrekil "the pharma bro", etc. - and the shareholders have been paying the price for the fallout. The 13D group was spot on - again, their main point was the Nader would destroy the company - and here we are at a share price that is 90% lower from when they were saying that.

My point regarding Tanya is that while we have purged the worst elements (Nader and his buddies) we still have very weak links that would never be present at a real company. Tanya is former wealth management advisor and a lawyer - that's fine - but no way on earth she should be COB at a real company (and at a company where the COB should have some industry expertise). Again, if we were on a real exchange, with real investors - an activist would have come in and purged her years ago.

I'm still long (and somewhat exhausted). I still think there is some value in this drug - and at least we're not committing fraud, submitting incomplete information to the FDA, and bragging about $100 SP on random webcasts. But having an overly conservative, and totally inexperienced (in the biotech world) COB is troubling. And while i like him, Jay doesn't give me confidence that we'll see value at any point in the near or intermediate future. There is no "lack of urgency here" - and i think the investors who have suffered for years and watched their investment implode damn well deserve a sense of urgency to restore some value. What we really need is a deal-maker - someone focused on restoring value as quickly as possible.

Lets be real. Why would someone who is highly credible come to work for this company? They are either here for a big check for misleading shareholders or else they are a very poor judge of characters. Either way, why would you want them? Wouldn't your Dr Jay be able to get hired on to a successful and growing pharma company?
People really need to recognize already what a penny stock is and why it is.
You are correct about Tanya Urbach though and her purpose.
Your Dr Jay has just informed you that any product is still 5 years down the road.
Meanwhile, PFE is selling currently at a P/E of 11 and a 5.7% dividend, AND they raise the dividend annually.
I don't care where you waste your money, but it seems like you're starting to get it.

Even worse (if possible) someone that promoted weed/wine to a position beyond his abilities. Then rewarded/Awarded him --ONCE AGAIN WITH BOARD APPROVAL (can ANY be trusted??) Shareholder equity--OUR shareholder equity-- means ZERO toTonya and board

After ALL that he and his daddy mickey did to defraud shareholders--just disgusting

That is prob the best thing Dr J did --mandatory removal of weed/wineornodeal Lucille (tonya)
Used a lot of his leverage and now she has a grudge

No doubt the timeframe is the chasm. Maybe shellshock after years of fraud and millions (hundreds of millions??) lost eroded gone to fraud--up in smoke--handed out like candy
There is NOT 1 person I would trust beyond Dr J and possibly Cohen as it stands

Have seen a COB and 1 board member and 1 CEO complete destroy this company and product. Hired crook books and son weed/wine. Even after ALL that Tonya not only kept weed/wine she promoted and rewarded. Took a few years but shareholder equity gone. SEC and DOJ involved. FDA punishment and doghouse

If Recknor or Rahman or Patterson are needed by Dr J by all means. (after the screwjob when they did nothing wrong)

See IF Timmons and/or Patel would be willing to come back on board (literally) (after the screwjob when they did nothing wrong)
See if Dr Seethamraju would be amenable (after the screwjob when he did nothing wrong)

All believed in Leronlimab at some point. All were honest and a lot more interested in advancing LL than using it as a ATM.

If there is ANYONE at NIH or Drexel that is still in position--let Dr J talk (BEG) to those and apologize and see if any of that funding/grants can be restored for trials (after the screwjob)

Its hilarious to read how some are still upset at Pestell and the "acquisition". Asking where is that prostate test. Give us back those millions of shares. Yet they deny the SEC filing by CYDY that states there is NO PROSTATE TEST being acquired. They deny the endrun by nodder around the SEC to avoid a shareholder vote. They NEVER complain about the millions of shares nodder got from board/award for "acquisition"

defending someone who has presided during a period when shareholders have lost 85% of their investment value shows that you're likely a paid promoter for the company. you certainly don't speak for real shareholders who have lost their hard-earned money under the stewardship of Tanya and this board.

Tanya is doing an excellent job all the way around. More power to her. Naysayers dressed up like longs have many times revealed a lack of real due diligence and only seek to put downward pressure on the stock price by posting BS.

We get it. But wait, there's more....>>>>
Recently a tried and true long TOOK THE WORDS RIGHT OUT OF MY MOUTH.
How obvious the soft bashing and the innuendos.
Dr. J is doing such a good job he has to be beat over the head with a bunny rabbit!
The game is obvious. Not one person who cares at all for improving lives would bad mouth
this company in any way shape or form. The few who legitimately spoke out against the ex
CEO's pilfering are to be commended, but not those who just merely rode in on the coattail
to supplement their bashing. There is a great distinction to be make of this.

Be that as it was(is).... we still see some who can only dip into the past since we are off to a new
start making great strides in the pharma world. Nice to be on good terms with these agencies! Dr. J brings a whole lot to the table.

Say, how would anyone like to see a new head of the FDA, CDC, NIH etc giving leronlimab a real up and up evaluation?
I would venture to say the short stumpers would vanish and CYDY would get some timely approvals and maybe even a EUA or two!!

EXCELLENT JOB Tanya and CYTODYN TEAM. YOU ARE ALL TO BE CONGRATULATED FOR HANGING TOUGH. $CYDY$ 2024

this is spot on. she is terrible - her background has nothing to suggest that she can add any value to a company. she's a lawyer, who had a background at a wealth management firm. way too conservative - but beyond that, i don't think she has even basic business skill.

of course the problem has been that the company had no money to pay anyone good to come in - tough to attract talent with a stock at all time lows, and no cash in the bank. i had hoped the new infusion of capital would attract a new CEO, with a business focus. I would think that CEO (if good) would keep Jay at CMO, and then immediately demand competent board members - because we don't have any.

we'll see. I'm afraid we'll be stuck with her and the same zombie crew we've had for years. Doesn't mean the company will fail - just means we're many years from making any money here.

Tanya has been --is--absolute disaster for legit CYDY shareholders. She is--as you allude --here ONLY for paulson/privvy place qualified purchasers. Disaster for schlepps that buy open mkt shares--while Tonya and her minions get below mkt shares and free warrants

That is 1 thing that Dr Lalezare AND Cohen --really should ( NEED ) to explain to all--so all can see/understand; why there are not shares sold at mkt prices with registration thru SEC. Sorta like real cos operate--Have some shelf shares--can sell as needed at full price.

With the 100s of millions of shares that have been wasted on Pestell acquisition and nodder awards. 100s of millions of shares doled out to Welch/Naydenov /kelly --highest compensated board in the Northwest and for what?? ____________________??

Hundreds of millions wasted on PR firms. Wasted on khazempour kickback scheme. Wasted on lawsuits. Wasted on awards for lost lawsuits. Wasted on nodder divorce/not divorce fiasco. Wasted on disaster manuf costs. Wasted flying execs around to poster presentations and free trips. Wasted paying massive salaries while Clinical holds were in place to the very people that caused the clinical holds. Wasted rewarding weed/wine because tonya needs a BFF with benefits

We need to get some of the legit board members back. We need to get Dr Lalezare some help. He is OTJ training and trustworthy so --compared to past--compared to what might be drug up by the dogs and the cats wont drag off; For me he is great CEO all things considered

I have been a long for quite a few years. Under the leadership of tanya urbach and other board members who seem to be working for paulson rather than cydy,the stock has crumbled. Any other head would be fired,but its like paulson wants her there. We continue to go in circle never getting very far. We are at a burn rate of about million per month,but we were told enough for testing. This is very far fetched. I think jay trying to do his best but board members have him on very short leash. I think there are some opportunities but there is no great leader to bring us forward.

What can I say I love watching people lose money it tickles me

What an erudite rationale. Amazing that you associate with "garbage penny stocks."

Guy please
1st I know/remember who embraced the items/persons mentioned. And also those that attacked me a few years back because I spoke truth/linked SEC docs and been proven correct. Don't be mad at me for for your analysis/opinion that has been proven wrong

ANYONE--even you--can go back and see your posts/history from 2020-21-22

Don't embarrass yourself further.

There are 2 rules to holes.
#1 realize when you are in one
#2--stop digging

Companies only send letters to shareholders when they don't have any real updates but need to keep people from selling so they can keep their paychecks. I see it a lot with garbage penny stocks.

Funny you "forget" when you posted MANY times how nodder was doing a great job. That HIV approval was certain. That you had much experience in medical industry and knew how great the nodder/kelly/mulholland team was from your experience and"uplisting" was imminent.

Yet now --SOMEHOW--the company is "in the woods" and being led out????

Go back to your embrace of jimmy chuckles/blackops/nodder et al

Remember how you hated 13D because they stated there would need to be maybe 200 million shares of dilution to remove amawrecks and fund actual trials?? What was that 400 million shares ago??

There is still no trial being conducted nor has there been a trial conducted without amawrecks--CORRECT??
Tell us AGAIN what does "imminent" mean
Tell us again about minimal dilution

In all your communications with nodder--did he tell you about the "blips" in HIV treatment?? In all your communications with nodder did he
tell you khazempour was on CYDY committees??

Might reflect on how WRONG your/opinions have been over the years--100% WRONG

Might want to understand difference in bash and truth. Not hard if you try. Wonder what has done the most damage for years. The bashing or the embrace of fraudulent CEO and his pumper minions

Leronlimab deserves better

It's nice to get a letter - but how about a phone call for investors where we can ask questions?

As for the letter, it was well written and organized. But it adds to my conviction that we are likely years away from catalysts that will restore any real value to shareholders - by real value, i mean anything over .50. Much of the updates were "starting to enroll in 2025" - that means any meaningful data is 2-3 years out.

Part of the CEO's job is the communicate, and get investors excited (and maybe attract new investors). Sending out quarterly letters further makes me question whether Jay is the right man for the CEO role. I do like him - but he may be more of a CMO type.

The mCRC (MSS) trial was to begin in 2022--combo with Regorafenib
It was last updated in FEB 2023 then "withdrawn" a few weeks later

Notice the 2023 update still showing amawrecks

NCT05730673

link here--https://clinicaltrials.gov/study/NCT05730673?cond=colorectal%20cancer&intr=leronlimab&rank=1

Good post. This is what it is all about. We sit on a miracle drug that finally is getting off high center no thanks to Dr. Falsi whose HIV Pharma babies had his utmost devotion keeping all others at bay for many years. Well, this extended over into China Virus Syndrome too, unfortunately into many other indications that would lead one to believe the CCR5 was practically not more than hidden crook gone amuck. Plus now, it has been learned the immune system as well receives stimulation so we have a dual action going on.

Now years later, it has taken a herculean effort by some real champions to keep this God sent medicine into the realm of real science. So as truth never can be kept silent forever, we finally have a great board of directors and one of the world's best minds who has probably more knowledge about CCR5 than most.

God Bless Dr. Jay and the whole team that has given new life to leronlimab. We know it works, they know it works, so bring on the challenges and let's keep the good news out front. Remember. safety first...which by the way the miracle drug is safe, very safe.

Thanks for your posting Trding.

I haven’t been following closely lately here, but I am guessing it is because this is an area of need and one that matches previous research, with other ccr5 trials and papers. I am guessing they suspect that is the fastest way to approval, because with good results the time to approval can be greatly shortened compared to those cancers with good results already. Also they have a good way to show the drug is working with measuring crcs directly as direct evidence is needed for fast approval.

Example:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407580/

“CCR5 expression was found to increase with primary tumor size and peaks in T4 CRC tumors (metastatic colon cancer). In liver metastases, CCR5 intensity increased, compared to primary tumors, but the stain was detected in small isolated areas (patchy staining). Low CCR5 expression in metastases was found to characterize patients with prolonged disease-free survival and disease-specific survival. Patchy CCR5 expression in cancer cells is a signature of liver metastases, and maraviroc was still effective in patients with CCR5 “patchiness”.




The C-C chemokine receptor type 5 (CCR5) plays a role in colorectal cancer (CRC) progression and is associated with several factors, including:

Tumor size
CCR5 expression increases with tumor size, and peaks in T4 CRC tumors, which are metastatic colon cancer.


CCR5 expression increases in liver metastases compared to primary tumors, but is detected in small, isolated areas.

Disease-free survival
Low CCR5 expression in metastases is associated with prolonged disease-free survival and disease-specific survival.

Tumor microenvironment
CCR5 signaling increases the infiltration of regulatory T-cells and myeloid-derived suppressor cells into the tumor microenvironment. This can contribute to cancer survival and progression, and may make tumors resistant to immunotherapy.

Macrophage repolarization
CCR5 is a potent regulator of macrophage repolarization. It promotes a proinflammatory, prometastatic phenotype of tumor cells.

Mesenchymal stem cells (MSCs)
MSCs produce large quantities of CCR5, and the CCL3/4/5-CCR5 axis promotes tumor progression.

re. "relapsed/refractory micro-satellite stable colorectal cancer (“CRC")"

What is the prior research backing this clinical indication? Seems out of the blue to me.

How about this from one of your questions, which I think is the most relevant. "How much $$$ do they have to survive...?


CYDY has enough cash on hand to commence the contemplated clinical trials.

If any of the trials or other resources takes... no new shares will have to be issued....

You should probably read this. The entire article is important, but this should quash to 2025 talk.

Oncology – September 2024 Updates

Our top priority remains the investigation of leronlimab in the field of oncology. As recently announced, CytoDyn is initiating a Phase II study of leronlimab in patients with relapsed/refractory micro-satellite stable colorectal cancer (“CRC”). Our synopsis proposal for the study was reviewed via a meeting with the FDA in August, and our final protocol is being submitted this week. We will continue to provide updates on this trial in the coming weeks, and expect to start screening patients in early 2025.

https://lifesciences.n-side.com/blog/what-is-the-average-time-to-bring-a-drug-to-market-in-2022

What’s the average time to bring a drug to market?
According to industry group PhRMA, it takes 10-15 years on average to develop one new medicine from initial discovery through regulatory approval.

Other sources corroborate this number. Biotechnology Innovation Organization (BIO), another industry group, analyzed 9,704 clinical development programs over the course of a decade from January 2011 to November 2020. They found that, on average, it took 10.5 years for a drug to get from Phase I to regulatory approval.

Looking at individual stages of the process, the averages were 2.3 years for Phase I, 3.6 years for Phase II, 3.3 years for Phase III, and 1.3 years between Phase III and regulatory approval.

According to BIO, a drug’s disease area impacts how long it takes to get to market. While 10.5 years was the average for drugs across all disease areas, averages for specific areas ranged from 9.2 to 12.2 years. At the lower end were drugs focused on allergic, metabolic, and infectious diseases. Meanwhile, drugs focused on neurological, cardiovascular, and urologic diseases had the longest development timelines.

Glad to see you are catching up. I bought more first thing this morning before it hit .16. I knew the PR was coming from the action last week.
We have a miracle drug. I am proud to be part of it as a shareholder.

Thanks!

https://finance.yahoo.com/news/september-2024-letter-shareholders-123000229.html

"....As of today, the Company has a new and improved relationship with the FDA -- one that will remain a critical priority for the management team in the coming years. We believe the Company has sufficient cash on hand to commence the contemplated clinical trials and push our development initiatives forward into 2025..."

From September 2024 Letter to Shareholders

https://finance.yahoo.com/news/september-2024-letter-shareholders-123000229.html

Spend some time. Happy reading.

There is a shareholder letter with many updates that was released 10 minutes ago

Welcome back.

Spend some time doing research. Happy reading.

For all jabbed and boosted and looking to take the next ones>>>> Here is some encouraging info.
https://rumble.com/v5dwc6l-500000-americans-have-been-killed-by-the-covid-vaccine-and-the-cdc-is-hidin.html?e9s=rel_v2_ep

So if the FDA could rubber stamp the jabs and hide evidence to the contrary, why could they not then
rubber stamp leronlimab that was far more tested and safer by huge ungodly amounts? We even had anecdotal evidence in abundance. Well, that chapter is behind us...wow, how time flies. Back at the ranch, Dr. Jay preparing for the new trial with the new CRO.

$CYDY$ 2024

Thank you, $5.95!

So, I guess Cytodyn only did the offer of 141M shares to sell in February 2024 and issued warrant tender offer in July 2024
How much $$$ do they have to survive before they will issue more shares?

Thanks upfront for the answer!

There has been no RS in the last two, there, four years.

Could anyone please tell me when the last dilution was? I think about 2 years ago was a reverse split, but I can't find any info on that.
Thanks, in advance!

My good buddy djjazzyjeff is here as he is a part of team Patterson. Keep in mind team Patterson hired Steven Gluk to help them work on advancing a CC5r platform. Anything dj can do to help eliminate support for P140 is his number one reason for being here.

Hey you're out! How does that sun feel?